Previous Article | Next Article ![]()
Journal of Clinical Microbiology, September 2009, p. 3000-3003, Vol. 47, No. 9
0095-1137/09/$08.00+0 doi:10.1128/JCM.01119-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Patrick Basset,2,
Auwalu Uba,3
Johnson Lin,4
Bukola Oyawoye,3
Adebayo O. Shittu,5 and
Dominique S. Blanc2*
Department of Medical Microbiology, University of Maiduguri Teaching Hospital, Maiduguri, Nigeria,1 Service of Hospital Preventive Medicine, University Hospital, Lausanne, Switzerland,2 Department of Biological Sciences, Abubakar Tafawa Balewa University, Bauchi, Nigeria,3 School of Biochemistry, Genetics and Microbiology, University of KwaZulu-Natal, Durban, Republic of South Africa,4 Department of Microbiology, Obafemi Awolowo University, Ile-Ife, Nigeria5
Received 8 June 2009/ Returned for modification 8 July 2009/ Accepted 10 July 2009
Ninety-six clinical isolates of Staphylococcus aureus from Nigeria were characterized phenotypically and genetically. Twelve multidrug-resistant methicillin (meticillin)-resistant S. aureus (MRSA) isolates carrying a new staphylococcal cassette chromosome mec element and a high proportion of Panton-Valentine leukocidin (PVL)-positive methicillin-susceptible S. aureus (MSSA) isolates were observed. The cooccurrence of multidrug-resistant MRSA and PVL-positive MSSA isolates entails the risk of emergence of a multidrug-resistant PVL-positive MRSA clone.
Published ahead of print on 15 July 2009.
These authors contributed equally to this study.
Copyright © 2010 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»